Defining the Minimal Important Difference for the Visual Analogue Scale Assessing Dyspnea in Patients with Malignant Pleural Effusions
Open Access
- 15 April 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (4) , e0123798
Abstract
The minimal important difference (MID) is essential for interpreting the results of randomised controlled trials (RCTs). Despite a number of RCTs in patients with malignant pleural effusions (MPEs) which use the visual analogue scale for dyspnea (VASD) as an outcome measure, the MID has not been established. Patients with suspected MPE undergoing a pleural procedure recorded their baseline VASD and their post-procedure VASD (24 hours after the pleural drainage), and in parallel assessed their breathlessness on a 7 point Likert scale. The mean decrease in VASD in patients with a MPE reporting a ‘small but just worthwhile decrease’ in their dyspnea (i.e. equivalent to the MID) was 19mm (95% CI 14-24mm). The mean drainage volume required to produce a change in VASD of 19mm was 760ml. The mean MID for the VASD in patients with a MPE undergoing a pleural procedure is 19mm (95% CI 14-24mm). Thus choosing an improvement of 19mm in the VASD would be justifiable in the design and analysis of future MPE studies.Keywords
This publication has 14 references indexed in Scilit:
- Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea in Patients With Malignant Pleural EffusionJAMA, 2012
- Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010Thorax, 2010
- Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomesJournal of Clinical Epidemiology, 2008
- Minimally important differences were estimated for the Functional Assessment of Cancer Therapy–Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approachesJournal of Clinical Epidemiology, 2005
- Measurement Properties and Interpretability of the Chronic Respiratory Disease Questionnaire (CRQ)COPD: Journal of Chronic Obstructive Pulmonary Disease, 2005
- Issues for Statisticians in Conducting Analyses and Translating Results for Quality of Life End Points in Clinical TrialsJournal of Biopharmaceutical Statistics, 2004
- Measuring the Dyspnea of Decompensated Heart Failure With a Visual Analog Scale: How Much Improvement Is Meaningful?Congestive Heart Failure, 2004
- Clinically Meaningful Changes in Quantitative Measures of Asthma SeverityAcademic Emergency Medicine, 2000
- Bias and Precision in Visual Analogue Scales: A Randomized Controlled TrialAmerican Journal of Epidemiology, 1999
- Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem seriesEuropean Respiratory Journal, 1989